Susceptibility to autoimmune diseases results from the encounter of a complex and long evolved genetic context with a no less complex and changing environment. Major actors in maintaining health are regulatory T cells (Treg) that primarily dampen a large subset of autoreactive lymphocytes escaping thymic negative selection. Here, we directly asked whether Treg participate in defining susceptibility and resistance to Experimental Autoimmune Prostatitis (EAP). We analyzed three common laboratory strains of mice presenting with different susceptibility to autoimmune prostatitis upon immunization with prostate proteins. The NOD, the C57BL/6 and the BALB/c mice that can be classified along a disease score ranging from severe, mild and to undetectable, respectively. Upon mild and transient depletion of Treg at the induction phase of EAP, each model showed an increment along this score, most remarkably with the BALB/c mice switching from a resistant to a susceptible phenotype. We further show that disease associates with the upregulation of CXCR3 expression on effector T cells, a process requiring IFNγ. Together with recent advances on environmental factors affecting Treg, these findings provide a likely cellular and molecular explanation to the recent rise in autoimmune diseases incidence.
. Murine models of autoimmune disease relying on immunization with autoantigens offer the possibility to focus on a defined tissue target and dissect susceptibility factors others than those involved in the original immunological stimuli 3, 4 . According to the auto-antigen used as immunogene, mouse strains display specific disease susceptibility or resistance. For instance alpha-myosin or collagen immunization induces experimental autoimmune cardiomyopathy or arthritis, respectively, in BALB/c but not in C57BL/6 mice, while similar immunization with myelin oligodendrocyte glycoprotein leads to encephalomyelitis in the latter but not in the former strain [5] [6] [7] . Other models of induced autoimmunity rely on immunization with total protein extract of a given organ, multiplying the number of antigens in a single protocol and thus presumably enlarging the repertoire of effector cells, as is the case for experimental autoimmune prostatitis (EAP) where the immunogene is a protein extract of the whole prostate 8 . In these type of models too, the combination of strain and antigen mixture defines the outcome of immunization, and EAP is evident in NOD and C57BL/6 but undetected in BALB/c mice 9 . The most commonly evoked notion to explain susceptibility/resistance to organ-specific autoimmunity is that MHC-antigen complexes are heterogenous in number or affinity among different strains 10 . Alternatively, as selection of the TCR repertoire appears to result in the purging of autoreactivity, this process may be more or less efficicient in various strains 11 . However, in most models of immunization with self-protein, antigen specific immune response can be detected whether disease follows or not, indicating that other layers of immune control, beyond the engagement of effector cells, condition the evolution to disease 12 . Intriguingly, the notion that some strains are biased toward specific cytokine profiles, e.g. Th1 for C57BL/6 and Th2 for BALB/c mice, hardly explain the mirror image presented above, i.e. that the same strain is susceptible to some inflammatory diseases and not to others 13 . Together, these observations leave open the possibility that specific control, dampening the progression of immune responses at the site of immunization to organ infiltration and associated tissue destruction, partipates in resisting the pathological process 14 . Among those, suppression by regulatory T cells (Treg) is a possibility, as these cells are now known to exert other functions in addition to their role in preventing effector cell activation 14, 15 . Null mutation in Foxp3, a transcription factor necessary and required for Treg differentiation and function 16 , unleashes a large repertoire of auto-reactive cells that escape negative selection and lead to a multiorgan autoimmune disease that is fatal in early age in both mice and humans 17 . Treg dampen immune responses in a cell contact or justacrine manner upon TCR engagement, through their expression of immunosuppresor cytokines (TGF-β and IL-10) and check-point molecules (CTLA4) 18, 19 . They were also recently implicated in tissue-healing and damage control, notably through the expression of amphiregulin 20 . Over the past decade our laboratory developed a mouse model of EAP 8, 9 that serves to mimick chronic prostatitis/chronic pelvic pain syndrome (CP⁄CPPS), one of the most prevalent diseases in urologic clinics 21 . CP⁄CPPS is an inflammatory disease that affects men younger than 50 years old in the absence of detectable infection 22 , and associates with Th1 like prostate specific reactivities 23 . Likewise, immunization of young adult males mice with prostate proteins together with adjuvants leads to prostatitis 8 , a progression strictly dependent on INFγ and the associated chemokine receptor CXCR3 9, 24 . Although all mice strains mount antigen specific responses upon immunization, NOD mice develop a severe disease, C57BL/6 animals exhibit moderate prostate infiltration and BALB/c mice show no prostate tissue alterations 9, 25 . We used the EAP model to assess the role of Treg in defining strain specific susceptibility or resistance to induced autoimmune disease. By treating mice with anti-CD25Ab to transiently deplete Tregs at the time of EAP induction, we reveal that these cells dampen a Th1/Tc1 response and ensuing prostrate infiltration, in all mice, including in the resistant BALB/c strain. These findings indicate that beyond genetic factors imposing strain intrinsic effector cell repertoire or tissue resilience, resistance to EAP is promoted by a regulatory mechanism that dampens a preexisting potential for tissue infiltration and associated destruction. In view of the natural dynamics and plasticity of Treg, these findings strengthen the notion that both genetic and environmental factors contribute to autoimmune disease susceptibility, the latter more easily explaining the recent rise in disease incidence.
Results
Both EAP susceptible and resistant mice mount an immune response upon prostate antigen immunization. To assess whether regulatory T cells naturally limit the induction of EAP in mice we tested three mouse strains presenting varying degree of susceptibility or resistance to the disease. We first choose to compare NOD, C57BL/6 and BALB/c mice that develop severe, mild and no disease, respectively 9, 25 . Animals were submitted to a single injection of the depleting anti-CD25 Ab (PC61), or of the isotype control rat IgG1 (YCATE), one day before immunization (Fig. 1A) . Analysis of Foxp3 expressing cells at steady state confirmed that NOD and BALB/c mice present the lowest and highest frequency of regulatory T cells, respectively 26, 27 . In all strains Foxp3 + cells expressed similar levels of Foxp3 and GITR and about half of them expressed CD25 ( Supplementary Fig. 1A ,B). Consistently with this phenotype, a single injection of PC61 leads to about 50% reduction in CD4 + Foxp3 + T cells and remove about 80-90% of CD4 + CD25 hi Foxp3 + T cells in all strains of mice, as tested 48 h post injection (Fig. 1B, Supplementary Fig. 1C ). This depletion is transient, and in absence of other interventions normal number of cells is recovered in the following 20 days 28, 29 . Immunization with prostate proteins (PAg) emulsified in CFA was conducted as reported before 9 and consisted of a priming injection followed by a boost 15 days later. Animals were analyzed at day 24, a time point our previous studies established as optimal for EAP evaluation 9, 24 . To assess the amplitude of the immune response we first measured serum Ig specific to prostate steroid-binding protein (PSBP, also named prostatein), an abundant immunogenic antigen from the prostate 30, 31 . As previously described 9 , all strains mounted a robust humoral response upon immunization, with high titers of antigen specific IgG1 and IgG2a/c. In the three strains, treatment with anti-CD25 Ab readily increased PSBP specific IgG2a/c titers as indicated by several log 2 differences (Fig. 1C) . We next monitored the extent of overall cellular activation by performing FACS analysis of spleen and lymph nodes draining the prostate ( Fig. 1D and Supplementary Fig. 1D ). Mice were analyzed in steady state conditions or after immunization and anti-CD25 or control Ab treatment. In all strains, immunization per se readily increased the number of CD62L low CD44 high memory/effector T cells recovered when compared to steady state conditions, and prior anti-CD25 Ab administration amplified this effect (Fig. 1D) . Similarly, the number of CD62L high CD44 high central memory T cells recovered upon immunization was increased in mice that were pretreated with anti-CD25 ( Supplementary Fig. 1C ). In control as in treated groups, the response was higher in NOD than C57BL/6 mice, and BALB/c animals were the less responsive. Strikingly, in all strains, immunization per se readily increased the number of CD4 + Foxp3 + cells when compared to steady state conditions (Fig. 1D ). This increment was partially affected by prior anti-CD25 Ab treatment in NOD and BALB/c mice, but not in B6 animals, suggesting strain specific differences in the kinetics of Treg recovery/proliferation (Fig. 1D ). Together these results indicate that all 3 strains do mount an immune response, limited by CD25 + regulatory cells, upon PAg immunization.
CD25
+ regulatory cells dampen a Th1/Tc1 immune responses in both EAP susceptible and resistant mice. We further assessed the class of the immune response under the control of CD25 + regulatory cells in the three strains. Intracellular staining for IFNγ and IL-17 in gated CD3 + T cells from draining LN cells collected in the experiments described above revealed that anti-CD25 Ab treatment amplified a Th1/Tc1 rather than a Th17 response ( Fig. 2A) . To focus the analysis on antigen specific T cells, draining LN cells were maintained in culture in conditions favoring survival and expansion of PSBP specific cells 9 . Three days later, both recovered cells and culture supernatants were analyzed by FACS (Fig. 2B) and ELISA (Fig. 2C) , respectively. In agreement with previous work indicating that IFNγ is required for EAP 9, 24 , antigen specific IFNγ 
CD3
+ in the NOD strain after anti-CD25Ab treatment (Fig. 2B) . Analysis of culture supernatants corroborated the same pattern; anti-CD25 Ab treatment raised the level of antigen specific secretion of IFNγ in all strains, with treated BALB/c mice approaching the values obtained in untreated C57BL/6 animals, and treated C57BL/6 approaching the values obtained in untreated NOD mice (Fig. 2C) . In contrast, the antigen specific production of IL-17, while also increased upon anti-CD25 Ab treatment, was not strain specific. While the frequency of IL10 + CD3 + cell did not change, an increased IL-10 secretion (notably in NOD and BALB/c mice) was observed in anti-CD25 Ab treated mice, suggesting that other cells than T cells produced IL-10, and these are also under Treg control. Surface staining for the chemokine receptors CXCR3 and CCR6 respectively associated with Th1/Tc1 and Th17/Tc17 classes of response 32 , confirmed a Th1/Tc1 strain-specific pattern (Fig. 2D,E ). Antigen specific CXCR3 T cells were more abundant in NOD than C57BL/6 mice, and less prevalent in BALB/c animals, while CCR6 expression was not correlated to EAP susceptibility. As for IFNγ , CXCR3 analysis indicated that treatment with anti-CD25 Ab promoted a C57BL/6-like response in BALB/c animals and a NOD-like response in C57BL/6 mice ( Fig. 2D ,E).
CD25
+ regulatory cells prevent Prostatitis in susceptible and resistant mice. Prostatitis is clearly evidenced by immunohistochemistry on prostate tissue to reveal CD45 + leucocytes infiltration and to evaluate tissue damage (Fig. 3A,B) . Immunized control mice confirmed the high prevalence and severity of EAP in NOD mice, the milder manifestation in C57BL/6 animals and the absence of infiltrates in BALB/c mice. Treatment with anti-CD25 Ab at the induction phase enhanced tissue cell infiltration and destruction in both susceptible strains. Strikingly, the treatment promoted disease in the otherwise resistant BALB/c mice, with an incidence of 5 out of 6 tested animals, and a severity comparable to that of control C57BL/6 animals ( Fig. 3B ). Significant histological alterations were detected in prostate tissue from anti-CD25 Ab treated NOD mice consisting in diffuse perivascular and stromal mononuclear cell infiltration accompanied by edema and severe tissue disorganization. Prostate + CD45 + cells infiltrating the prostate gland from mice under study. Data are shown as mean ± SEM, n = 6 mice per group, and are representative of two independent experiments. The p values were obtained using one-way ANOVA followed by Bonferroni post-hoc analysis; ns, non significant. samples from anti-CD25 Ab treated C57BL/6 mice exhibited multifocal perivascular and stromal mononuclear cell infiltration. Finally, significant histological alterations were detected in prostate tissue from anti-CD25Ab treated BALB/c mice, consisting in focal perivascular and stromal mononuclear cell infiltration, accompanied by edema (Fig. 3A) .
We next quantified and characterized prostate infiltrating leukocytes by performing FACS analysis (Fig. 3C -F and Supplementary Fig. 2A ). In a remarkable concordance with the histological scores, the number of leucocytes (CD45 + ) or T cells (CD3 + ) recovered from prostate tissues were more elevated in NOD mice than in C57BL/6 animals (about 2 folds), and BALB/c presented with the lowest values. For these parameters too, administration of anti-CD25 Ab at the induction phase of EAP increased the values, such that treated BALB/c mice resembled control C57BL/6 animals and treated C57BL/6 mice resembled untreated NOD animals. When analyzing the leukocyte populations composing the infiltrate, CD3
+ and CD11b + cells were the most abundant while the frequency of CD19 + cells was low. These proportions were similar irrespective of anti-CD25 Ab treatment, with the exception of untreated healthy BALB/c mice which as expected exhibited lower frequency of CD3 + cells within the infiltrates (Fig. 3E) . Inside the CD3
+ cellular subset about 60% were CD4 + and 40% were CD8 + T cells, irrespectively of the strain or the treatments (Supplementary Fig. 2A ). In agreement with a major role for CXCR3 in promoting T cell migration from the lymph nodes to the tissue, the number of infiltrating T cells expressing this chemokine receptor positively correlated with disease severity (Fig. 3F) . Contrarily to our analysis of the draining lymph nodes (Fig. 2D) , the frequencies of T cells expressing CXCR3 in the infiltrates were constant across the different experimental groups (Supplemental Fig. 2B ). These results support the notion that CXCR3 expression is acquired in the lymph nodes and facilitates migration to the tissue. Finally, little or no CCR6
+ cells were detected in prostate infiltrates (Fig. 3F, Supplementary Fig. 2B ). Together, these results indicate that CD25
+ regulatory cells dampen a tissue specific Th1/Tc1 deleterious autoimmune response, triggered by immunization, in both EAP susceptible and resistant strains. In turn, this finding indicates that EAP resistance in BALB/c mice is not solely the result of efficient negative selection of the TCR autoimmune repertoire, or of poor antigen presentation.
+ regulatory cells dampen CXCR3 expression on effector T cells, a process requiring IFNγ. In a previous work, we evidenced that IFNγ is required for EAP occurrence through its essential role in the induction of CXCR3 expression by T cells, a mechanism of trans-regulation 9 . As anti-CD25 Ab treatment promoted both IFNγ and CXCR3 expression upon immunization, we next asked whether CD25
+ regulatory T cells affected CXCR3 expression independently of their role in dampening cytokine production. We analyzed NOD-IFNγ −/− mice that are fully resistant to EAP 9 . These mice mount a Th17/Tc17 type of response upon immunization as indicated by the presence of IL-17 producing and CCR6 expressing T cells in pooled draining LN at day 24 (Fig. 4A,B ). Both T cell phenotypes were amplified by anti-CD25 Ab administration before immunization, while CXCR3 expression remained undetectable (Fig. 4A,B) . In addition, NOD-IFNγ −/− treated with anti-CD25 Ab remained resistant to EAP showing no infiltration or damage in the prostate gland (Fig. 4C) . To allow for CXCR3 expression, we complemented the IFNγ deficiency by providing recombinant-IFNγ (rIFNγ ) through repeated injection during the boosting phase of the immunization 9 ( Fig. 4D ). This treatment per se promotes CXCR3 expression and increases the frequency of CXCR3 + cells in draining LN 9 . In the control conditions (vehicle only), and as observed above, anti-CD25 Ab treatment increased the frequency of cells expressing CCR6. In contrast, in presence of rIFNγ , anti-CD25 Ab treatment increased by twofold the frequency of antigen specific CXCR3 + cells, an increment associated with a twofold reduction in the frequency of CCR6 + cells (Fig. 4E ). This switch in the class of chemokine receptors expressed by T cells upon immunization, and its amplification by the depletion of CD25 + regulatory T cells, resulted in prostate infiltrations with evident tissue destruction (Fig. 4F) , to an extent similar to that observed in WT animals (see Fig. 3A ), and with a disease score close to 3. In the same animals, cellular analysis of prostate infiltrates revealed increased number of leucocytes and T cells (Fig. 4H) , reaching numbers similar to those observed in WT mice (see Fig. 3D ). From these data, we conclude that CD25 + regulatory cells dampen the differentiation of CXCR3 + cells, by a process independent of effector T cell autocrine IFNγ secretion.
Discussion
By performing limited and transient Treg depletion at the time of EAP induction in susceptible and resistant mice we reveal that, beyond strain specific repertoire or tissue resilience, a layer of immune control dampens pathological responses, to the point of conferring disease resistance to BALB/c mice. This approach applied to mutant mice also provided key information regarding the role of specific inflammatory cytokines and chemokine receptors in EAP onset. Together, this work provides new clues to our understanding of susceptibility to autoimmune disease and its variation in complex genetic and environmental settings, as it is the case for humans.
To assess the role of Treg in defining the susceptibility and severity to EAP we choose a loss of function approach and resorted to anti− CD25 antibody mediated cellular depletion. The CD25 molecule is expressed by most Foxp3
+ regulatory T cells, especially those functionally engaged in regulation 33 . It is also expressed by activated T cells, albeit transiently, a small subset of B cells, and few dendritic cells 34, 35 . While Ab mediated depletion may lack in specificity when compared to targeted genetic engineering, it offers the unique opportunity to test various genetic background in a short time. Moreover, available genetic models were not directly adapted to serve our objectives. Mice bearing a null mutation in the Foxp3 gene are fully deficient in Treg and develop spontaneously a severe and multi-organ pathology leading to early death 36 , a model not easily amenable for strain specific analysis and not adapted for the case of prostatitis as death occurs before full development of the prostate (unpublished observation). Animals bearing the diphtheria toxin receptor gene under the transcriptional control of Foxp3 allow for Treg depletion in adults, however discrepancy of results across the available models 37, 38 still await disambiguation before engaging in organ and strain specific analyses. Moreover, diphtheria toxin has side effects in mice, and more specifically, its toxicity is increased when combined with adjuvants like CFA 39 . Administration of a single dose of the monoclonal anti-CD25 Ab PC61 in mice, induces a depletion of CD25 expressing cells that is transient, due to Ab clearance and homeostatic rebound 28 , and cannot be prolonged due to the Ab intrinsic immunity in mice (unpublished observations). In addition to cellular depletion, PC61 may functionally inactivate the remaining Treg through antibody-mediated blockade of IL-2 signaling 40, 41 . However, depletion and functional inactivation remain moderate as no manifestation of systemic or tissue specific autoimmunity has ever been reported or noted 42 (and unpublished observation) upon a single injection of PC61. We found that a reduction in regulatory cell number during the priming phase of EAP was enough to break down self-tolerance in the resistant BALB/c strain and worsen disease severity in both the mildly and the highly susceptible C57BL/6 and NOD mice, respectively. A role for Treg in preventing spontaneous prostatitis occurrence in susceptible mice has been evidenced earlier. Neonatal thymectomy in mice results in spontaneous autoimmunity targeting varying organs, including the prostate 43 . Several line of evidences indicate that disease in this system results from alteration in Treg repertoire and function, and specifically, adoptive transfer shortly after day 3 thymectomy of Treg isolated from healthy donor prevents EAP 44 . In our system, effector and potentially pathogenic cells are primed and boosted by the immunization, and transient Treg depletion evidence that negative selection does not explain disease resistance in BALB/c mice. As acknowledged above anti CD25 Ab targets other cells than Treg. In a model of induced Autoimmune Experimental Uveitis, C57BL/6 mice treated with anti CD25 Ab showed decreased numbers of Treg but also γ δ T cells and CD11c + CD3 − CD25 + dendritic cells that could explain the observed reduced Th17 and enhanced autoreactive Th1 response 35 . In our study we did not discriminate the relative contribution of Treg and other CD25 expressing cells in defining EAP susceptibility.While additional layers of regulation may well take place, our results establish that susceptibility and resistance to EAP is defined by dominant regulatory mechanisms and not merely by recessive tolerance.
Previous studies have reported that Treg depletion may converts specific strains from a non-responder to a responder phenotype in infectious setting (e.g. ref. 45 ). In setting of autoimmunity, most studies used Treg depletion to evidence their protective role in animals prone to spontaneously develop disease. This is the case of a recent work revealing that transient Treg depletion induced by administration of a low dose and very short regimen of diphtheria toxin in Foxp3-DTR mice induces disease in BALB/c CrSlc, a substrain well know for its susceptibility to gastritis 46 . In our experimental setting of induced autoimmunity, immunization provides for normalization of the priming event, across strains. With this approach, the role of regulatory cells in susceptibility or resistance to disease can be addressed beyond questioning, or eluding, the still obscure issue of the original tissue-antigen specific priming of pathogenic cells.
Despite Treg depletion prior to immunization, BALB/c mice developed a moderate immune response and a mild disease, comparable to those occurring in untreated C57BL/6 animals. As previously reported, we found higher frequencies of CD4 + Foxp3 + cells in peripheral lymphoid organs of BALB/c mice when compared with NOD and C57BL/6 animals, in steady state conditions 26, 27 . Moreover, BALB/c when compared to C57BL/6 Treg were shown to be more efficient at suppressing conventional cell 26 , a result not reproduced later 27 . It is conceivable that our partial depletion preserved antigen specific Treg in BALB/c more than in C57BL/6 mice, due to natural enrichment or higher efficiency in the former strain. Alternatively, BALB/c mice could carry less antigen specific conventional cells. The two notions seems actually related, as indicated by recent works confirming that the repertoire of self-reactive conventional and regulatory T cells is sorted according to specific properties of the interactions between the TCR and MHC-self-peptide in the thymus [47] [48] [49] , and it is easily conceivable that these properties are tuned by specific MHC alleles.
Our results evidence that in all strains disease severity associates with enhanced generation of antigen specific T cells expressing CXCR3, but not CCR6. In a previous work we showed that IFN-γ is required for EAP occurrence due to its specific role in promoting effector T cells migration to the prostate tissues 9 . This study also revealed that IFNγ acts in trans to upregulate CXCR3 and downregulate CCR6 chemokine receptors on effector T cells. In turn, this work indicated that irrespectively of whether effectors cells are IFNγ or IL-17 producers, it is their chemokine receptor expression pattern that determines their capacity to infiltrate the tissues. Here, in the three mouse strains under study, we show that a transient depletion of Treg cells at the inductive phase of the disease promotes a Th1/Tc1 response, with moderate effect on the Th17/Tc17 subset. In contrast, in mice deficient for IFNγ , the same treatment enhanced a robust Th17 response, although not associated with EAP. These results are consistent with the widely accepted notion that Treg inhibit a large range of immune cells, including Th1, Th17, Th2 and also CD8 + T cells. In our system, the context is imposed by CFA that provides the signal necessary to define the class of responses. In turn, our results support the notion that in wild type animals and under inflammation promoted by CFA, Treg dampen the dominant IFNγ responses even in the Th2 biased BALB/c background.
Th1 and Th17 pathogenic effectors cells once induced in the periphery must traffic to their target organs and this traffic is associated with the expression of specific chemokine receptors and also with the induction of appropriate chemokines in the target organ 50 . More relevant to the mechanism of autoimmune disease, our results also support the notion that the pathology results from the upregulation of CXCR3 on effector cells, rather than on specific cytokine profiles. This is best illustrated in our analysis of IFNγ deficient mice, where although effector cell numbers are increased through transient Treg depletion, these are pathologic only if exposed to IFNγ . In turn these results indicate that BALB/c mice are resistant to EAP, not because of a lack of potential to mount an antigen specific response, but owing to the inhibition of Th1/Tc1 response by Treg, that prevent the production of IFNγ required for effector cells migration to the prostate.
Choosing three strains to cover a spectrum of susceptibility, from the NOD with exacerbated disease, the C57BL/6 with mild inflammation and to the resistant BALB/c mice, we show that transient Treg depletion moves each strain to the next degree of severity: the severity of prostate infiltration in treated BALB/c animal is similar to that of untreated C57BL/6 and likewise treated C57BL/6 animals appear as affected as untreated NOD mice (Fig. 3) . This finding is striking as it indicates that mild disturbances in the Treg pool can confer susceptibility Scientific RepoRts | 6:33097 | DOI: 10.1038/srep33097 to a resistant strain, offering in turn a likely explanation to the recent rise in autoimmune disease incidence in developed countries 51 . This increment was too rapid to result from enrichment of the gene pool with susceptibility alleles. Along the hygiene hypothesis, societal factors such as systematic vaccination reduced the occurrence of repeated immune activation that otherwise follow pediatric infections, and in turn, altered intrinsic features of the immune system. Evidences that Treg differentiation, survival and expansion depend on IL-2 produced by effector cells 28, 52 , together with their ability to directly respond to TLR ligands 53 , and therefore bacterial, viral and extra-cellular matrix component, provided a cellular and molecular basis to the hygiene hypothesis. This theory predicts overall lower number or decreased robustness of Treg in "cleaner environment", a situation somewhat mimicked by transient and mild depletion of Treg as we performed here. In keeping with environmental and life-style changes, recent findings indicate that beneficial components of our microbiota promote Treg expansion and differentiation 54 , and the now routine practices of administrating frequent boost of antibiotics may have increased our susceptibility to autoimmunity.
Material and Methods
Mice and Antigens. Mouse strains used in this study were NOD/LtJ (NOD/ShiLtJ), C57BL/6 and BALB/c purchased from The Jackson Laboratory (Bar Harbor, ME). NOD-IFNγ −/− (NOD.129S7(B6)-IFN-γ tm1Ts ) mice were kindly provided by Dr. Diane Mathis and Christophe Benoist (The Jackson Laboratory). All animals were housed and maintained under SPF conditionsin the Animal Facilities of the Facultad de Ciencias Químicas, Universidad Nacional de Córdoba or the Instituto Gulbenkian de Ciência, and used at the age of 6-8 wk. All animal experiments were approved by and conducted in accordance with guidelines of the Committee for Animal Care and Use of the Facultad de Ciencias Químicas, Universidad Nacional de Córdoba and the ethics committee of the Instituto Gulbenkian de Ciência in strict accordance with the recommendation of the Guide to the Care and Use of Experimental Animals published by the Canadian Council on Animal Care (OLAW Assurance number A5802-01) and the Portuguese State Veterinary division (DGV).
The preparation of a mixture of prostate antigens (PAg) and the purification of Prostatein, or prostate steroid-binding protein (PSBP), were performed as previously described 55 . The purity of the PSBP preparation was > 95% as evaluated by Western blot and was LPS-free as tested by Gel clot 0.03 endotoxin units/ml sensitivity (Charles River, Laboratories International, Wilmington, NY, USA). EAP induction and histological prostatitis score. Six-to 8-week-old male NOD, C57BL/6, BALB/c or NOD-IFNγ −/− mice were subcutaneously immunized in the hind footpad and in the base of the tail with PAg (300 μ g/mouse) or saline solution emulsified in CFA (Sigma-Aldrich, St. Louis, MO, USA) in a total volume of 150 μ l/mouse. Mice received immunizations at days 0 and 15, and then were sacrificed at day 24 of the experimental schedule 9, 24 . The severity of EAP was assessed by determining the histological score, which was analyzed in a double-blind manner and computed for individual glands by summing the pathologic grade of each prostate tissue section and dividing by the total number of sections examined. The degree of inflammation was assessed using a score of 0 to 4:0, no inflammation; 1, mild but definite perivascular cuffing with mononuclear cells; 2, moderate perivascular cuffing with mononuclear cells; 3, marked perivascular cuffing, hemorrhage with some parenchymal inflammatory cells; 4, marked perivascular cuffing, hemorrhage and numerous mononuclear and mast cells in the parenchyma, in 5-mm-thick prostate tissue sections of each organ per animal that were processed by conventional hematoxylin and eosin staining. Slides were visualized in a microscope Nikon TE 2000U (Nikon, Osaka, Japan).
Antibodies. Commercially available antibodies used in different experiments

In vivo CD25
+ cell depletion. NOD, C57BL/6, BALB/c and NOD-IFNγ −/− mice were injected intravenously (i.v.) with 500 μ g of anti-CD25Ab (clone PC61). Control mice received the same amount of rat IgG Ab (clone YCATE) produced at the Instituto Gulbenkian of Ciência. Depletion was evaluated using anti-CD25 Ab (clone 7D4) and Foxp3 staining. Mice from all strains received anti-CD25 or IgG control Ab 1 day before starting the EAP immunization schedule as previously described 28 .
In vivo treatment with recombinant IFNγ. NOD-IFNγ Prostate antigen specific antibodies in serum. Prostate steroid-binding protein-specific IgG1, IgG2a-c serum levels were titrated by conventional ELISA using specific detection antibodies in multiwell plates (Corning, Costar, Cambridge, MA). Plates were precoated with 100 μ L per well of PSBP (20 mg/mL) in 0.05 M carbonate buffer of pH9.6. After overnight incubation at 4 °C, microwells were washed twice and blocked with 3% BSA (Sigma-Aldrich) in PBS for 2 hours at 37 °C, rinsed with PBS-Tween 20 at 0.05%, and then filled with 100 μ L of serum (obtained after cardiac puncture) serial dilutions (starting at 1/50) for 1 hour at 37 °C. To detect specific IgG1, IgG2a-c plates were again washed and incubated with HRP conjugated rat anti-mouse IgG1 or anti-mouse IgG2a-c (BD Biosciences) for 1 hour at 37 °C. Plates were thoroughly washed, and the reaction was developed with BD OptEIA TMB Substrate Reagent Set (BD Biosciences). Absorbance was measured at 450 nm in a microplate reader (Bio-Rad Laboratories, Hercules, CA). Serum reactivity was expressed in titer inversed values.
Cell culture. Single mononuclear cell suspensions were prepared in HBSS (Sigma-Aldrich) from spleen and pooled draining lymph nodes of individual mice by Ficoll-Paque PREMIUM 1.084 (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) centrifugation gradients. Live cells were counted by Trypan blue exclusion, resuspended in RPMI 1640-GlutaMAX medium (Life Technologies, Carlsbad, CA, USA) supplemented with 1% penicillin/streptomycin (Life Technologies), 50 mM 2-ME (Life Technologies), and 10% FCS (Life Technologies), and cultured in the presence of PSBP (20 μ g/ml) or medium alone. Plates were incubated at 37 °C in a water-saturated 5% CO 2 atmosphere for 72 hours. After that, cells were processed for surface or/and intracellular cytokine staining and analyzed by FACS. Supernatants were frozen at − 80 °C for cytokine quantifications.
Cytokine quantification. Cytokine secretion of cell suspensions was assessed after antigen stimulation at a cell density of 1.5 × 10 6 cell/ml. Cell suspension from spleen or prostate draining lymph nodes were stimulated during 72 h with PSBP (20 μ g/ml). IFNγ , IL-17A and IL-10 concentrations in culture supernatants were measured by ELISA using paired Abs or specific kits (eBiosciences for IL-17A, and BD Biosciences for IFN-γ and IL-10) according to standard protocols and following manufacturer's instructions.
Flow cytometry.
Freshly isolated mononuclear cells from spleen or LN were stained for surface markers and intracellular cytokines as previously described 9, 24 . To determine the expression of chemokine receptors, cells were stimulated in vitro with PSBP and then staining was performed. In other experiments, after in vitro stimulation with PSBP (20 μ g/ml) for 72 h, cells were incubated for 5 h. with 50 nM PMA and 0.5 μ g/ml ionomycin (Sigma-Aldrich) in the presence of Golgi Stop (BD Biosciences). Cell-surface staining of different molecules and chemokines receptors was performed followed by intracellular staining of different cytokines using the BD CytoFix/Cyto Perm and Perm/Wash kit (BD Biosciences) according to the manufacturer's instructions. Cells were incubated with APC-labeled antibodies to IL-17A (eBiosciences), or CCR6 (BioLegend), and with PE-labeled antibodies to IFNγ (BD Biosciences) or CXCR3 (BioLegend). Cells were acquired on FACS Canto II or FACS Calibur flow cytometer (BD Bioscience) and analyzed using FlowJo software (Tree Star, Ashland, OR, USA).
Analysis of prostate infiltrating leucocytes.
Prostate infiltrating leucocytes analysis was performed as previously described 9, 24 . Freshly harvested prostate tissue samples were mechanically disrupted and enzymatically digested in RPMI 1640 medium containing 1 mg/ml collagenase D (Roche, Basilea, Switzerland) and DNase I (Sigma-Aldrich) for 45 min at 37 °C. After digestion, suspensions were filtered through 75-and 40-μ m cell strainers (BD Biosciences) and single-cell suspensions were washed twice in 10% FBS, 2 mM EDTA, and 50 mM 2-ME supplemented RPMI 1640 medium. Live lymphocyte counts were deduced from the acquisition of a fixed number of 10-μ m latex beads (Beckman Coulter, Brea, CA, USA) mixed with a known volume of unstained cell suspension in propidium iodide (BD Biosciences). Analyses were performed allowing the exclusion of dead cells (propidium iodide positive) inside the indicated gates. After that, cells were stained with different antibodies for flow cytometry analysis. Cells were acquired using a FACS Canto II or FACS Calibur (BD Bioscience), and data were analyzed using FlowJo software (Tree Star, Ashland, OR).
Immunohistochemistry assays. Formalin-fixed and paraffin-embedded prostate sections were dewaxed in xylene, rehydrated, treated with Target Retrieval Solution (Dako Cytomation, Glostrup, Denmark) at 95 °C for 30 min, and blocked with FC blocking solution (BD Bioscience). Endogenous peroxidase activity was blocked with blocking buffer (Dako Cytomation). Then slides were incubated overnight at 4 °C in blocking buffer containing rabbit anti-CD45 (clone 30-F11) Ab. Slides were washed four times in 10 mM PBS, 0.1% Tween 20, and incubated with anti-rabbit HRP (BD Bioscience) secondary Abs for 2 h at room temperature. Colorimetric detection was performed by using Detection Kit (BD Bioscience) and counter stained with hematoxylin.
